Correction
In the October 2004 issue of the Journal, an article by Simpson et al. titled “Randomized, Controlled, Double-Blind Multicenter Comparison of the Efficacy and Tolerability of Ziprasidone and Olanzapine in Acutely Ill Inpatients With Schizophrenia or Schizoaffective Disorder” (Am J Psychiatry 2004; 161:1837–1847) contained errors in Figure 2 (incorrect number of ziprasidone-treated subjects and incorrect color coding of data plots). The correct figure appears below.
Figure 2. Least Squares Mean Changes in Clinical Global Impression (CGI) Severity Scale Score in Patients With Schizophrenia or Schizoaffective Disorder in a 6-Week Trial of Ziprasidone and Olanzapine
aNo significant differences between groups (last observation carried forward) (p=0.95, 95% CI=–0.27 to 0.29).
